WESTERN NEW YORK / ECMC - ADULT INDUCED HYPOTHERMIA STATUS POST CARDIAC ARREST ORDERS (PG 1 OF 5)

Similar documents
Therapeutic Hypothermia for Post Cardiac Arrest Plan Initial Orders

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Hypothermia Short Set-Critical Care HYPOTHERMIA SS- CRITICAL CARE

(31189) Hypothermia Initiation Phase One

Appendix C Guidelines for treating status epilepticus in adults and children

School Medication Authorization Form. School Grade Teacher. Emergency Phone No: To be completed by the student's physician: Name of Medication:

Therapeutic Hypothermia after Resuscitated Cardiac Arrest

National Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes

SECTION O. MEDICATIONS

Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

Printed copies of this document may not be up to date, obtain the most recent version from Author Position

SURGICAL NOTE. Surgical Recommendations to Optimize Femoral/Iliac Artery Cannulation

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for STROKE Stream of Care HYPERACUTE URGENT TIA and SECONDARY STROKE PREVENTION

INDUCED HYPOTHERMIA. F. Ben Housel, M.D.

Paediatric Sepsis Form. Sinéad Horgan SSWHG Sepsis Lead

3.If your hospital is a designated Trauma Centre, what is the designation level? o Level I o Level II o Level III

WARNING: FATAL AND SERIOUS TOXICITIES: SEVERE DIARRHEA AND CARDIAC TOXICITIES

Nova Scotia Guidelines for Acute Coronary Syndromes (2008) QUICK REFERENCE MARCH Supported by unrestricted educational grants from:

Annex III. Amendments to relevant sections of the Product Information

Cool It Induced Hypothermia Therapy Post Cardiac Arrest Learning Packet

Non-depolarizing Neuromuscular Blocking Agents

A Plasma Humoral Factor of Extrarenal Origin Causing Release of Reninlike Activity in Hypotensive Dogs

3. After I.V. or S.C. administration, onset is rapid, usually within 30 seconds, with duration of 5 to 10 minutes.

Baptist Health South Florida - Therapeutic Hypothermia for Comatose Survivors of Cardiac Arrest Critical Care / ICU Admission Orders

Standardize comprehensive care of the patient with severe traumatic brain injury

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

Stroke Reperfusion Therapy: IV t-pa Treatment Phase

OTHER AND UNSPECIFIED DISORDERS

Hypothermia in Neonates with HIE TARA JENDZIO, DNP(C), RN, RNC-NIC

Biventricular Pathway for infants 6 weeks to 1 year

SAN LUIS OBISPO COUNTY HEALTH AGENCY

National Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center

Drug Therapy Guidelines

Completing the NPA online Patient Safety Incident Report form: 2016

Getting Started. Learning Guide. with Continuous Glucose Monitoring for the MiniMed 530G with Enlite. CGM Foundations

ACRIN 6666 Screening Breast US Follow-up Assessment Form

Commissioning Policy: South Warwickshire CCG (SWCCG)

Guidelines for the Admission of Children and Young People with an Eating Disorder

INTRAVENOUS FLUID THERAPY CLINICAL CARE RECOMMENDATIONS

Clinical Study Synopsis

Urine Alkalinization. Passawat Na Nakorn, MD. R 3 Emergency Medicine

BP Thresholds for Medical Review

Critical Care Treatment Guidelines

ACEM Fellowship Examination Emergency Medicine Practice Questions SAQ

Pain relief after surgery

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Intravenous Fluid & Acidbase Balance for Surgical. Patients

Low Molecular Weight Heparin Prescribing and Administration (Adults)

Section 5. Study Procedures

Ischemic heart disease (angina/chest pain)

Rate Lock Policy. Contents

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

ADULT POST NEUROLOGIC INTERVENTION ORDERS 2 of 4

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital

Solid Organ Transplant Benefits to Change for Texas Medicaid

VENTRICULAR ASSIST/Heart Assist DEVICES BEST PRACTICES GUIDELINE

EASTERN ARIZONA COLLEGE Advanced Cardiovascular Life Support

Package leaflet: Information for the user. Fragmin Graduated Syringe 10,000 IU/ml Solution for Injection dalteparin sodium

Appendix 1 Example of Homely Remedy Policy

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

Package leaflet: Information for the user. Dacepton 5 mg/ml Solution for infusion Apomorphine hydrochloride hemihydrate

Part 1 describes the reasoning and recommendations up to node 2 of the algorithm.

Methadone Maintenance Treatment for Opioid Dependence

Section J. Health Conditions

2017 Optum, Inc. All rights reserved BH1124_112017

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

Field Reference Protocol 2016

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745

5.0: Rare Bleeding Disorders

Tips & Tricks COMPASS Improvements March 5, 2014

PEDIATRIC LIFEGIFT BRAIN DEATH PLAN

Percutaneous Nephrolithotomy (PCNL)

Physician Orders ADULT: Renal Transplant Admit Plan

National Hospital Inpatient Quality Reporting Measures Specifications Manual Release Notes

Emergency Department Performance Measures

Neurosurgery Pre-Op [1710] Patient Name MRN. General. Nursing. Case Request [ ] Case request operating room Scheduling/ADT, Scheduling/ADT [ ] Other

BROCKTON AREA MULTI-SERVICES, INC. MEDICAL PROCEDURE GUIDE. Date(s) Reviewed/Revised:

GUIDANCE DOCUMENT FOR ENROLLING SUBJECTS WHO DO NOT SPEAK ENGLISH

Urinary Retention: Inability to pass urine despite the presence of urine in the bladder.

Protocol. Preparation Protocol for the Non-Targeted Vevo MicroMarker Contrast Agent

Understanding Your Total-Cholesterol-to-HDL Ratio

PEDIATRIC PRIMARY SPONTANEOUS PNEUMOTHORAX

Procedure Information

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip

PICU ADMIT DKA PLAN - Phase: Begin Immediately

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

EMC believes the information in this publication is accurate as of its publication date. The information is subject to change without notice.

Opioid Analgesics PA Request Provider Checklist

Medical Student Immunization Requirements

INDIVIDUALIZED HEALTHCARE PLAN DIABETES WITH INJECTION HEALTHCARE PROVIDER ORDERS

Acute Transfusion Reactions Shan Yuan, MD Updated May 19, 2011

POST-OP CARDIAC SURGERY PHYSICIAN S ORDER SHEET USE BALLPOINT PEN ONLY. CARDIAC INTENSIVE CARE UNIT

Postoperative Anterior Cruciate Ligament Reconstruction Care WITH meniscus repair:

Transcription:

Name: STATUS POST CARDIAC ARREST ORDERS (PG 1 OF 5) Date f Birth: Rm: Inclusin Criteria Nn Traumatic Cardiac Arrest with Return f Spntaneus Circulatin (ROSC) Cre Temperature greater than (34 C) at presentatin Time t initiatin f hypthermia is less than 6 hurs Cmatse after ROSC : GCS less than 8 and n purpseful mvements t pain Exclusin Criteria Uncntrlled GI bleeding Severe CHF knwn t be present at baseline (NY Heart Assciatin class III r IV) Knwn terminal illness r pre-arrest impaired cgnitive status (unable t perfrm ADL independently) Cnflict with Advanced Directives r DNR status Cardivascular instability as evidenced by : Uncntrllable arrhythmias Refractry hyptensin (unable t achieve target MAP f 75 mm Hg despite interventins) Sepsis as suspected cause f cardiac arrest Suspected intracranial hemrrhage Majr intracranial, intrathracic r intrabdminal surgery within 14 days Gravid pregnancy Check bx t activate desired rders. ORDERS AND PHYSICIAN S SIGNATURE This is nt a stand alne rder set; MUST be used in cnjunctin with unit specific admissin rders) DATE : TIME : (TIME f ROSC : ) ADMIT STATUS : Admit t CCU Admit t ICU DIAGNOSIS : S/P Cardiac Arrest. ADMITTING Allergies/Intlerances/Nature f reactin : PHYSICIAN : CONSULTS : LINE PLACEMENT : PHASE : TIME STARTED : VITAL SIGNS : IV : Critical Care/Pulmnary Neurlgy n all patients Other Arterial line placement (MUST have Arterial line placed) Cling device set up unless placed in ED CVP catheter needed Place temperature - sensing fley t mnitr temp ( 1/4-1/8" adapter fr cling device) (GOAL is t get cre temp t 32-34 C within 6 hrs f nset f arrest) If cre temperature is greater than (34 C) at initiatin f prtcl, blus with refrigerated (4 C) 0.9% NaCl until patient s cre temperature is (34 C). Blus at 100mL/min with a maximum f 2 liters ttal; this is t include ED and EMS vlume. May btain cld saline frm ED. (Omit if 2 L already given by EMS r ED). Place ice packs arund head, neck, axillary areas, and grin fr 20-25 min (include EMS time). Initiate cling device prtcl fr 24 hurs with machine t 33 C, unless t cath lab, start prtcl after lab. Place fley; temperature prbe t cling device. Place rectal prbe t cardiac mnitr fr secndary surce f temperature Crrelate and recrd secndary temp every 2 hurs. Dcument surce f secndary temp (may be rectal r central catheter). IF patient has recurring arrhythmias, discntinue active cling, begin re-warming & call MD STAT. IF unable t btain target cre temperature cnsult MD fr further cling rders BP, MAP, HR, O2 sat, and cardiac rhythm every 15 min x 4, every 30 min x 4 then hurly and prn. Check CVP every hur. Recrd fley temperature every 15 minutes until (32-34 C) is achieved. Then every 30 minutes until rewarming cmpleted. D nt cl less than (32 C) 0.9% Sdium Chlride at ml/hr If pssible, fluids shuld be dextrse free with the exceptin f standard infusins r Rx f hypglycemia.

Name: STATUS POST CARDIAC ARREST ORDERS (PG 2 OF 5) BP & VOLUME MANAGEMENT : ANALGESIA Date f Birth: Rm: Gal is MAP > 75 and < 120 mm Hg Replace urine utput every 1 hur with : 0.9% NaCl 0.45% NaCl Lactated Ringers using : 0.5 ml / 1 ml IVF replacement t urine utput 1 ml / 1 ml IVF replacement t urine utput Observe clsely fr fluid verlad. CVP gal f 6-10 mmhg Additinal IV vlume supprt : Nrepinephrine IV start at 0.5 mcg/min and titrate as needed t keep MAP greater than 75. Other pressr agent : Nitrglycerin IV, start if MAP ver 120 r. Start at 5 mcg/min, increase by 5 mcg/min increments every 3-5 min unitl a BP respnse is nted. Use nnverbal pain scale t assess fr pain/discmfrt prir t administering a Neurmuscular Blcking Agent Gal fr analgesia : less than 3, n the 1-10 Nnverbal Pain Scale, r minimal pain behavirs. APP scale will be used fr patients receiving Neurmuscular Blcking Agent r prpfl. Fentanyl mcg/hr (range: 0.5-2 mcg/kg/hr) cntinuus infusin. (Cnsider if patient is hemdynamically unstable r has renal insufficiency, r if GFR < 30 ml/min.) OR : 0-2 n pain 3-6 mderate pain 7-10 severe pain - use app Mrphine mg (0.1 mg/kg lad; typically 5-10 mg), then mg/hr IV cntinuus infusin (range: 0.8-10 mg/hr IV) If piate verdse in differential (small pupils, unrespnsive and/r track marks), cnsider : Nalxne : 0.4 mg IV ; (may rder every 2-3 min as needed up t 2 mg; d nt cl further if awakens and neurlgic deficit reslves) SEDATION Lrazepam : mg IV x 1 (range 1-2 mg) Midazlam : mg/hr (range 2-5 mg/hr) NEUROMUSCULAR BLOCKING AGENT (Fr preventin f shivering) DVT PROPHYLAXIS STRESS ULCER PROPHYLAXIS Prpfl Infusin : mcg/kg/min (5 mcg/kg/min initially) cntinuus infusin, titrate every 5 minutes until at gal (range : 5-50 mcg/kg/min IV). Mnitr triglycerides after 48 hurs. Dsing nt t exceed 80 mcg/kg/min. Vial and tubing must be changed every 12 hurs. Cnsider discntinuing prpfl after 2 days; cnsult with MD fr further sedatin requirements. Befre starting neurmuscular blcking agent, verify that the patient is adequately medicated with analgesic and sedative agents at gal and receiving mechanical ventilatin. Obtain baseline "train f fur" then every 1 hur. Adjust degree f neurmuscular blcking agent t achieve 2/4. If unable t btain train f fur, titrate neurmuscular blcking agent t prevent shivering. Vecurnium : mg (0.1 mg/kg) IV blus x 1 (unless full neurmuscular blcking agent blus given by ED r EMS) Vecurnium : mcg/min (range : 0.8-1.2 mcg/kg/min) cntinuus infusin. (Standard pharmacy slutin). Avid in significant renal r hepatic impairment. If significant renal (GFR < 30) r hepatic dysfunctin, cnsider: Cisatracurium : mg (0.2 mg/kg) IV blus x 1 (unless full neurmuscular blcking agent blus given by ED r EMS) Cisatracurium : mcg/min (range : 2.5-3 mcg/kg/min) cntinuus infusin Sequential cmpressin devices (SCDs). Use Ft Pumps if unable t use SCDs Heparin 5000 units subcutaneusly every 8 hurs OR : Enxaparin 40 mg subcutaneusly daily (autmatic adjustment fr GFR < 30 ml/min) Famtidine 20mg IV every 12 hurs stress ulcer prphylaxis (autmatic substitutin permissable) If GFR < 30 ml/min, give Famtidine (Pepcid) 20 mg IV every 24 hurs.

STATUS POST CARDIAC ARREST ORDERS (PG 3 OF 5) OTHER MEDICATIONS Date f Birth: Rm: Lacrilube t bth eyes every 4 Hurs and PRN while n neurmuscular blcking agent. Fr intubated/trached patients : Fllw ICU Oral Care Plicy NURSING : VENT MANAGEMENT : Insert NG/OGT t lw cntinuus wall suctin Intake and utput hurly; Call MD if urine utput is less than 0.5 ml/kg/hr despite abve vlume given Mnitr CVP and A-line; use saline flush nly fr pressure line D NOT bathe patient during hypthermic r rewarming perid Vent Settings : N warm humidified air ABG every (maintain PaCO2 35-45) IF NOT DONE IN ED : STAT LABS : STAT DIAGNOSTICS LABS EVERY 6 HOURS X 24 HRS BMP Trpnin UA PCXR CBC, BMP and ABG CBC PT/PTT Serum & Urine Tx Serum Albumin PCXR 12 lead ECG BMP PT/PTT 12 HOURS Bld Culture x 2 AFTER START OF PROTOCOL DAILY Ca/Magnesium/Phs CBC with diff Ca/Magnesium/Phs Lactate Type & Screen Ntify MD if Hgb < 10 ABG (temp crrected) Urine HCG Female (Age 10-55) OTHER LABS OR DIAGNOSTICS ELECTROLYTE REPLACEMENT Trpnin every 8 hurs x 24 hurs CK s every hurs x D nt replace ptassium unless serum ptassium is less than 3mEq/L during cling phase. Call MD fr specific replacement dse. Make sure time t rewarm phase is cmmunicated. DO NOT USE PRE-EXISTING ELECTROLYTE REPLACEMENT ORDERS

STATUS POST CARDIAC ARREST ORDERS (PG 4 OF 5) Date f Birth: Rm: **************** PHASE: A. TIME STARTED: B. TIME STARTED IN ED: C. TIME FINISHED: ********************************************************************************************************** Target Temperature (36.1-37 C) Begin rewarming 24 hurs frm time cling was started Target temperature t be btained in apprximately 18 hurs; STOP re-warming nce (36 C) is reached t prevent versht. Rewarming gal f 0.17 C/hr. Remve warming garments frm patient. Empty fley at start f rewarming. Strict I & O (see vlume relacement sectin) Activate re-warming (prgram warming device fr 0.17 C/hr and 36 C). Call MD if warming > 0.5 C/hr. If external cling devices used, remve cl packs. May place warm blankets (d NOT use Bair Hugger) if needed Mnitr temp/vs/rhythm clsely every 30 minutes until target temp is reached, then every 1 hur x 12 additinal hurs, fllwed by temp/vs every 4 hurs IF patient remains nrmthermic r mre if cnditin warrants Cntinue sedatin and neurmuscular blcking agent until temperature is equal t r greater than 36 C. (Discntinue neurmuscular blcking agent first, then wean sedatin.) D nt permit temperature greater than 37 C in first 24 hurs after cling phase. IF temp greater than (37 C) administer acetaminphen Cntinue labs as rdered (anticipate increase in ptassium) Cntinue mnitring I & O every 1 hur (anticipate hypvlemia) Once nrmthermic gal reached at end f 48 hurs, cnsult with MD service fr D/C f femral line if present. Acetaminphen : Rute 650 mg abve 37 C X 48 hurs. per feeding NG tube PR If given via tube, clamp x 30 min. Dsage nt t exceed 4 gm / 24 hurs every 4 hurs PRN temp SHIVERING : Observe fr shivering every 1 hur If ff neurmuscular blckade, and shivering ccurs during rewarming phase apply warm blankets. Hydrmrphne 1 mg IV, may repeat in 5 minutes x 1 IF abve methds(s) ineffective, call MD STAT fr further rders (may need t restart neurmuscular blcking agent and sedatin). Physician signature required : Transcribed by : Checked by (Nurse) : Beeper # : ---

1) 2) STATUS POST CARDIAC ARREST ORDERS (PG 5 OF 5) Date f Birth: Rm: Physician Infrmatin (Guidelines - d nt replace physician judgment) Ptassium less than 3.4 meq/l early in cling (first 12 hurs) - replace Ptassium Chlride with 40 meq by NG Ptassium less than 3.0 meq/l late in cling (12-24 hurs) - replace Ptassium Chlride with 40 meq by NG (Ptassium tends t rise n rewarming) 3) 4) 5) 6) 7) Hgb less than 10 - Transfuse PRBCs Platelets less than 30,000 - transfuse 2 packs Platelets 30,000-50,000 with bleeding transfuse 2 packs During rewarming there is an smtic diuresis - replace vlume slightly greater than 1 : 1 t urine utput Treatment f Hyperglycemia (nn-diabetic) : glucse 200-249 - 2 units reg insulin, 250-299 - 3 units reg insulin, 300-349 - 4 units reg insulin, 350-400 - 5 units reg insulin 8) 9) INR > 2 crrect with FFP 2-4 units + vitamin K (if n Warfarin) Temp < 31 C - cnsider 250 ml blus f warmed 0.9% nrmal saline and warming blanket 10) Unable t cl t temp 32-34 C - cnsider 250-500 ml 4 degree 0.9% sdium chlride 11) Magnesium < 1.7-2 grams Magnesium Sulfate IV 12) Crrected Calcium < 8.4 - Calcium Chlride 1 gram IV (Calcium level shuld be crrected fr decreased albumin : Crrected calcium (mg/dl) = measured ttal Ca (mg/dl) + 0.8 (4.0 - serum albumin [g/dl]), where 4.0 represents the average albumin level) ** NOTIFY MD IF : Magnesium < 1.7 Crrected Calcium < 8.4 Ptassium < 3.4 Hgb < 10 Platelets < 30,000 Platelets 30,000-50,000 with bleeding Glucse > 200 Temperature Cnversin Chart C F 31 32 87.8 89.6 33 91.4 34 93.2 35 95 36 96.8 36.1 96.98 37 38 98.6 100.0 39 102.2